Frazier Life Sciences Management, L.P.
Position in KALV — KalVista Pharmaceuticals, Inc.
CIK 1892134
PALO ALTO, CA
Position in KALV
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$99,867,104
+$18,473,252 QoQ
Shares Held
4,961,108
-1.6% QoQ
Ownership
9.32%
of shares outstanding
% of Portfolio
2.58%
of 13F equity value
Holder Rank
#2
of 182 holders
Holding Since
Mar 2022
17 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in KALV Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026Frazier Life Sciences Management, L.P. holds $3,802,745,091 across 34 Biotechnology names. KALV ranks #12 (2.6% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MIRM |
Mirum Pharmaceuticals, Inc.
|
7,679,684 | $709,449,207 | |
| 2 | NAMS |
NewAmsterdam Pharma Co N.V.
|
16,943,774 | $542,370,205 | |
| 3 | ERAS |
Erasca, Inc.
|
24,675,188 | $399,244,541 | |
| 4 | BBIO |
BridgeBio Pharma, Inc.
|
3,448,139 | $256,058,802 | |
| 5 | ARQT |
Arcutis Biotherapeutics, Inc.
|
9,874,511 | $232,643,479 | |
| 6 | MBX |
MBX Biosciences, Inc.
|
6,652,013 | $198,562,588 | |
| 7 | PHAT |
Phathom Pharmaceuticals, Inc.
|
12,466,489 | $138,502,692 | |
| 8 | MAZE |
Maze Therapeutics, Inc.
|
4,567,274 | $136,333,128 |
All Filings in KALV
Export CSV
17 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $99,867,104 | 4,961,108 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $81,393,852 | 5,039,867 | Shares | Sole | 2026-02-13 | |
| 2025-09-30 | $61,385,580 | 5,039,867 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $55,257,336 | 4,887,867 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $56,405,985 | 4,887,867 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $41,400,233 | 4,887,867 | Shares | Sole | 2025-02-18 | |
| 2024-09-30 | $42,705,499 | 3,687,867 | Shares | Sole | 2024-11-15 | |
| 2024-06-30 | $43,443,073 | 3,687,867 | Shares | Sole | 2024-08-15 | |
| 2024-03-31 | $43,738,102 | 3,687,867 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $44,373,101 | 3,622,294 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $31,190,212 | 3,238,859 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $29,149,731 | 3,238,859 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $25,457,431 | 3,238,859 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $21,894,686 | 3,238,859 | Shares | Sole | 2023-02-07 | |
| 2022-09-30 | $22,812,505 | 1,572,192 | Shares | Sole | 2022-11-14 | |
| 2022-06-30 | $15,470,369 | 1,572,192 | Shares | Sole | 2022-08-10 | |
| 2022-03-31 | $23,174,110 | 1,572,192 | Shares | Sole | 2022-05-16 | |
| No filing history on record for this holder in this stock. | ||||||